Position in PLRX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$520,122
+$206,094 QoQ
Shares Held
412,796
+60.4% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PLRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Laurion Capital Management LP holds $287,143,589 across 18 Biotechnology names. PLRX ranks #17 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
1,262,651 | $93,764,463 | |
| 2 | MLYS |
Mineralys Therapeutics, Inc.
|
2,232,040 | $60,465,963 | |
| 3 | IMUX |
Immunic, Inc.
|
3,882,162 | $43,091,998 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
7,822,638 | $33,559,117 | |
| 5 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
|
1,922,656 | $17,207,771 | |
| 6 | PYXS |
Pyxis Oncology, Inc.
|
4,997,333 | $7,296,106 | |
| 7 | VOR |
Vor Biopharma Inc.
|
318,670 | $5,685,072 | |
| 8 | PEPG |
PepGen Inc.
|
2,750,855 | $4,869,013 |
All Filings in PLRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $520,122 | 412,796 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $314,028 | 257,400 | Shares | Sole | 2026-02-17 | |
| 2024-06-30 | $26,863,390 | 2,498,920 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $51,773,685 | 3,474,744 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $64,898,398 | 3,583,567 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $55,254,100 | 3,186,511 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,233,288 | 3,158,570 | Shares | Sole | 2023-08-14 | |
| 2022-06-30 | $3,769,514 | 470,601 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||